Summit Partners Public Asset Management’s Procept Biorobotics PRCT Stock Holding History

Summit Partners Public Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-410,292	Closed	-$23.9M	–	181
2025 Q1	$23.9M	Sell	410,292 -141,475	-26%	-$9.66M	0.61%	58
2024 Q4	$44.4M	Buy	551,767 +8,721	+2%	+$745K	0.85%	43
2024 Q3	$43.5M	Sell	543,046 -219,648	-29%	-$15.6M	1.35%	27
2024 Q2	$46.6M	Sell	762,694 -4,050	-0.5%	-$241K	1.78%	22
2024 Q1	$37.9M	Buy	766,744 +428,246	+127%	+$20.4M	1.3%	28
2023 Q4	$14.2M	Buy	+338,498	New	+$11.5M	0.59%	70

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Summit Partners Public Asset Management's PRCT Position: Q2 2025 in Review

Summit Partners Public Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 410,292 shares — an estimated $23.9M sold.

Summit Partners Public Asset Management first reported a position in PRCT in Q4 2023 and held it in 6 quarters. The position peaked at $46.6M in Q2 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

Summit Partners Public Asset Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
Summit Partners Public Asset Management sold 410,292 Procept Biorobotics shares in Q2 2025, an estimated $23.9M.
Summit Partners Public Asset Management first reported a position in Procept Biorobotics in Q4 2023 and held it in 6 quarters.
Summit Partners Public Asset Management's Procept Biorobotics position peaked at $46.6M in Q2 2024.
271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.